Rosuvastatin Unknown Status Phase 4 Trials for Angioplasty / Acute Coronary Syndromes (ACS) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Unknown Status | Treatment | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01245803 | Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS | |
| NCT02077257 | LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients |